- £365.22m
- £1.33bn
- £148.70m
- 21
- 68
- 43
- 37
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 138 | 139 | 140 | 140 | 149 |
Cost of Revenue | |||||
Gross Profit | 111 | 110 | 108 | 108 | 113 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -45.1 | 20.1 | 33 | 205 | 372 |
Operating Profit | 183 | 119 | 107 | -65 | -223 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 159 | 96.5 | 91.5 | -82 | -263 |
Provision for Income Taxes | |||||
Net Income After Taxes | 135 | 77.4 | 120 | -81.9 | -250 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 136 | 77.4 | 120 | -81.9 | -250 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 136 | 77.4 | 120 | -81.9 | -250 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.334 | 0.19 | 0.295 | -0.201 | -0.629 |
Dividends per Share |